Global Renal Denervation Devices Market: Snapshot
At the forefront of driving the global renal denervation (RDN) devices market is the rising cases of hypertension particularly among the urban denizens. This is because renal sympathetic nerves are affected directly by hypertension. Another factor serving to boost the global renal denervation (RDN) market is the growing pool of elderly and emergence of better RDN devices.
However, one problem besetting the global renal denervation devices market is the inadequate clinical data which creates hurdles in getting approvals from regulatory bodies for new products. This is somewhat hampering the market growth at present. Leading players with means have nonetheless managed to get approvals for their products because of their cutting-edge research and development facilities innovating on existing products. So far, just five devices have managed to get a regulatory nod for usage. They are now CE certified.
At present, the global renal denervation devices market is consolidated with leading player Medtronic holding most of the share in it. In the near future, the market might see new entrants denting shares of established players. A report on the global renal denervation devices market finds that it is rising at a phenomenal CAGR and would likely pull in a value of US$1.9 bn by 2021.
Radiofrequency-based RDN Devices See Surging Demand owing to Safety they Accord
Technology-wise, the key segments of the global renal denervation devices market are renal sympathetic denervation procedure, ultrasound- based renal denervation systems, micro-infusion catheter-based renal denervation systems, and radiofrequency-based renal denervation systems. Among them, currently, the radiofrequency-based RDN devices holds maximum share in the market. This is because of the advantages it accords. Those include safety and time-efficiency.
Some of the key products available in the global renal denervation devices market are Boston Scientific's (Vessix Vascular) V2, ReCor Medical's Paradise, St. Jude's EnlighHTN, Medtronic's Symplicity, and Covidien's OneShot. While Medtronic’s Symplicity held an outsize share in overall sales in the market a while back, newer products are giving it tough competition these days.
Europe Largest and Fastest Growing Market
Geographically, the global renal denervation devices market is spread across North America, Asia Pacific, Europe, and the Rest of the World. Among them, Europe at present holds the tag of both the biggest and fastest growing market. The region is seeing double digit growth. North America is another key renal denervation devices market which is witnessing solid growth owing to the FDA approvals of new products. Rising occurrence of cardiovascular diseases in the region too is having a positive impact on demand. Meanwhile, the Asia Pacific renal denervation market is also showing a lot of promise. This is mainly because of the high occurrence of diabetes which is boosting demand in the regions. Developing economies of India and China are main drivers of the region’s market growth because of their large populations.
Some of the prominent participants in the global renal denervation devices market are Kona Medical, Medtronic Inc., St. Jude Medical, Boston Scientific Corporation, Mercator Medsystems, Covidien PLC, and CardioSonic.
1. Introduction
1.1. Research scope and description
1.2. Renal Denervation Devices: Market Segmentation
1.3. Research Methodology
1.3.1. Sources
1.3.1.1. Secondary Research
1.3.1.2. Primary Research
1.4. Assumptions
2. Executive Summary
3. Global Renal Denervation Devices Market Analysis
3.1. Background
3.1.1. Hypertension
3.1.2. Treatment resistant hypertension (trHTN) & uncontrolled hypertension (uHTN)
3.1.3. Current trends in resistant hypertension treatment
3.1.4. Role of renal sympathetic nerves in hypertension
3.1.5. Renal denervation treatment
3.1.6. Risks associated with renal denervation
3.2. Market Drivers For Renal Denervation
3.2.1. Increasing cases of uncontrolled and treatment resistant or drug resistant hypertension (trHTN) driving the market
3.2.2. Short duration and permanent effect of renal denervation procedure is expected to drive the market
3.2.3. Rapid development of RDN devices and aging population globally growing at parallel levels to drive the market
3.3. Market Restraints For Renal Denervation
3.3.1. Shortage of clinical evidence restraining the expansion of the market
3.3.2. Lower awareness of RDN devices as compared to drug-based therapy
3.3.3. Unstable reimbursement regulations expected to be another barrier for RDN devices
3.4. Opportunities in Renal Denervation Market
3.4.1. Emerging economies to be high growth opportunity regions
3.4.2. Merger and acquisition opportunities
3.5. Porters Five Forces Analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. Threat of new entrants
3.5.4. Threat of substitutes
3.5.5. Competitive rivalry
3.6. Market Attractiveness Analysis: Global Renal Denervation Devices Market, by Geography, Scenario in 2021
4. Global Renal Denervation Devices Market Analysis, By Technology
4.1. Renal Sympathetic Denervation Procedure
4.1.1. Overview
4.1.2. Trends in renal denervation technologies
4.2. Radiofrequency-based Renal Denervation Systems (RF-RDN)
4.2.1. Overview
4.2.2. Market Trends
4.3. Ultrasound-based Renal Denervation Systems (US-RDN)
4.3.1. Market Trends
4.4. Micro-infusion catheter-based Renal Denervation Systems
4.4.1. Overview
4.4.2. Market trends
5. Global Renal Denervation Devices Market Analysis, By Products
5.1. Medtronic - Symplicity Renal Denervation System
5.1.1. Product Description
5.1.2. Market Trends
5.2. St.Jude Medical - EnligHTN Multi-Electrode Renal Denervation System
5.2.1. Product Description
5.2.2. Market Trends
5.3. Covidien - OneShot
5.3.1. Product Overview
5.3.2. Market Trends
5.4. Boston Scientific (Vessix Vascular) - V2. Renal Denervation System
5.4.1. Product Description
5.4.2. Market Trends
5.5. ReCor Medical - PARADISE Technology (Percutaneous Renal Denervation System)
5.5.1. Product Overview
5.5.2. Market Trends
5.6. Other Emerging Technologies
5.6.1. Kona Medical - Surround Sound Renal Denervation System
5.6.2. CardioSonic - TIVUS
5.6.3. Mercator - Bullfrog Micro-Infusion Catheters
5.6.4. Sound Interventions - Sound 360
6. Renal Denervation Market Analysis, By Geography
6.1. Overview
6.1.1. Global Renal Denervation Devices Market, By Geography, 2012-2021 (USD Million)
6.2. North America
6.2.1. North America Renal Denervation Devices Market, 2012-2021 (USD Million)
6.3. Europe
6.3.1. Europe Renal Denervation Devices Market, 2012-2021 (USD Million)
6.4. Asia-Pacific
6.4.1. Asia-Pacific Renal Denervation Devices Market, 2012-2021 (USD Million)
6.5. Rest of the World
6.5.1. RoW Renal Denervation Devices Market, 2012-2021 (USD Million)
7. Competitive Analysis: Renal Denervation Market
7.1. Market Share of Key Players: Comparative Analysis, 2012 & 2015
7.2. Competitive Landscape: Company Profiles
7.2.1. Medtronic Inc.
7.2.1.1. Company Overview
7.2.1.2. Financial Analysis
7.2.1.3. Strategies
7.2.1.3.1. Merger & Acquisition Strategies
7.2.1.3.2. New Product development
7.2.1.4. Product Portfolio
7.2.1.5. Recent Developments
7.2.2. Kona Medical
7.2.2.1. Company Overview
7.2.2.2. Financial Analysis
7.2.2.3. Strategies
7.2.2.3.1. Investment through venture capitalists
7.2.2.4. Product Portfolio
7.2.2.5. Recent Developments
7.2.3. St.Jude Medical
7.2.3.1. Company Overview
7.2.3.2. Financial Analysis
7.2.3.3. Strategies
7.2.3.3.1. Significant R&D investment for quality product development
7.2.3.3.2. Global Expansion with technology advancement
7.2.3.4. Product Portfolio
7.2.3.5. Recent Developments
7.2.4. Boston Scientific Corporation
7.2.4.1. Company Overview
7.2.4.2. Financial Analysis
7.2.4.3. Product Portfolio
7.2.4.4. Strategies
7.2.4.4.1. Merger and Acquisitions
7.2.4.4.2. New Product Development
7.2.4.4.3. Recent Developments
7.2.5. Covidien PLC
7.2.5.1. Company Overview
7.2.5.2. Financial Overview
7.2.5.3. Product Portfolio
7.2.5.4. Business Strategies
7.2.5.4.1. Focused research and development activities
7.2.5.4.2. New Product development
7.2.5.4.3. Merger and acquisition
7.2.5.5. Recent Developments
7.2.6. Mercator Medsystems
7.2.6.1. Company Overview
7.2.6.2. Product Portfolio
7.2.6.3. Business Strategies
7.2.6.3.1. Strategic partnership
7.2.6.3.2. Develop advanced technology products
7.2.7. CardioSonic
7.2.7.1. Company Overview
7.2.7.2. Product Portfolio
7.2.7.3. Recent Developments
List of Tables
TABLE 1: Renal Denervation Devices - Market Snapshot
TABLE 2: RDN devices market size and forecast, by technology, 2012-2015 (USD million)
TABLE 3: RDN devices market size and forecast, by technology, 2015-2018 (USD million)
TABLE 4: RDN devices market size and forecast, by technology, 2018-2021 (USD million)
TABLE 5: Comparative Analysis of Energy Sources in Renal Denervation Devices
TABLE 6: RDN devices market size and forecast, by products, 2012-2015 (USD million)
TABLE 7: RDN devices market size and forecast, by products, 2015-2018 (USD million)
TABLE 8: RDN devices market size and forecast, by products, 2018-2021 (USD million)
TABLE 9: RDN devices market size and forecast, by geography, 2012-2015 (USD million)
TABLE 10: RDN devices market size and forecast, by geography, 2015-2018 (USD million)
TABLE 11: RDN devices market size and forecast, by geography, 2018-2021 (USD million)
List of Figures
FIG. 1: Renal Denervation Devices: Market Segmentation
FIG. 2: Global Renal Denervation Devices Market, 2012-2021 (USD Million)
FIG. 3: Comparative Analysis: Global Renal Denervation Devices Market, by Products, 2016 & 2021 (%)
FIG. 4: Porter’s Five Forces Analysis: Renal Denervation Devices Market
FIG. 5: Market Attractiveness Analysis: Global Renal Denervation Devices Market, by Geography, 2021
FIG. 6: Global Renal Denervation Devices Market, By Geography, 2012-2021 (USD Million)
FIG. 7: North America Renal Denervation Devices Market, 2012-2021 (USD Million)
FIG. 8: Europe Renal Denervation Devices Market, 2012-2021 (USD Million)
FIG. 9: Asia-Pacific Renal Denervation Devices Market, 2012-2021 (USD Million)
FIG. 10: RoW Renal Denervation Devices Market, 2012-2021 (USD Million)
FIG. 11: Comparative Analysis: Market Share of Key Players (2012 & 2015)
FIG. 12: Comparative Analysis: Market Share of Key Players (2015 & 2018)
FIG. 13: Comparative Analysis: Market Share of Key Players (2018 & 2021)
FIG. 14: Medtronic Inc.: Annual Revenues, 2010-2012 (USD Million)
FIG. 15: St.Jude Medical: Annual Revenues, 2009-2011 (USD Million)
FIG. 16: Boston Scientific Corporation: Annual Revenues, 2010-2012 (USD Million)
FIG. 17: Covidien PLC: Annual Revenues, 2010-2012 (USD Million)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Renal Denervation Devices (Symplicity, EnligHTN, OneShot, V2, Paradise, TIVUS, Bullfrog, Surround Sound, Micro-Infusion, Ultrasound and Radiofrequency) Market
